Summary of opinion: Cosentyx Positive
Submitted by Anonymous (not verified) on 18 September 2026 - 11:05
Summary of opinion: Cosentyx Positive
Summary of opinion: Ocrevus, 17/09/2026 Positive
Submitted by Anonymous (not verified) on 18 September 2026 - 11:05
Summary of opinion: Ocrevus, 17/09/2026 Positive
Human medicines European public assessment report (EPAR): VaxRabeo, rabies vaccine (inactivated) for human, Status: Opinion
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Human medicines European public assessment report (EPAR): VaxRabeo, rabies vaccine (inactivated) for human, Status: Opinion
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026
Summary of opinion: Pradaxa, 17/09/2026 Positive
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Summary of opinion: Pradaxa, 17/09/2026 Positive
Summary of opinion: Jyseleca Positive
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Summary of opinion: Jyseleca Positive
Withdrawn application: Kaftrio, 01/09/2026
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Withdrawn application: Kaftrio, 01/09/2026
Summary of opinion: Abiraterone Mylan, 17/09/2026 Positive
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Summary of opinion: Abiraterone Mylan, 17/09/2026 Positive
Benefits of sodium oxybate continue to outweigh risks in people with alcohol dependency
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
Benefits of sodium oxybate continue to outweigh risks in people with alcohol dependency
EMA concludes review of ipidacrine-containing medicines
Submitted by Anonymous (not verified) on 18 September 2026 - 11:00
EMA concludes review of ipidacrine-containing medicines